On February 25, the VU Life Sciences Center (LSC) was visited by representatives of the University of Greifswald: Rector of the University, Prof. Katharina Riedel, Head of the Interdisciplinary Centre for Baltic Sea Region Research (IFZO), Dr. Alexander Drost, and Coordinator of the DAAD Project "Teaching Internationally," Thomas Jenssen.

Groundbreaking development of single-cell -omics tools by Vilnius University (VU) Life Sciences Center (LSC) scientists – Dr Greta Leonavičienė and Prof. Linas Mažutis – has paved the way for advancements in biotechnology. Their research have led to a $25 million Series A investment in the biotech startup "Atrandi Biosciences."

"When the people you've admired on stage for years listen to your lecture... when you get to step behind the scenes, feel the theater’s magic, and be surrounded by its muses… it’s like a dream!" – this is how Dr. Eglė Lastauskienė, a researcher at Vilnius University Life Sciences Center, describes her experience working with actors. She was invited to consult the Lithuanian National Drama Theatre troupe as they prepared for the premiere of "Fermentacija" – a play about an unusual biological revolution where microorganisms challenge humans.

Martyna Koplūnaitė has defended her thesis entitled "Chemoenzymatic synthesis of nucleoside 5'-monophosphates" for the degree of Doctor of Science in Biochemistry.

As cancer diagnostics continue to evolve, the ability to detect and treat the disease at an early stage is improving significantly. One of the recent groundbreaking innovations is liquid biopsy – a method that detects genetic mutations without invasive procedures. Alongside this, genetic and epigenetic research is increasingly critical in advancing cancer diagnostics and treatment.

Dear Scientists,

On the occasion of the International Day of Women and Girls in Science, we sincerely congratulate you and express our gratitude for your significant contributions to science and innovation. This day not only highlights your exceptional achievements but also inspires young girls to pursue their goals in the field of science boldly.

To mark this special day, we share the thoughts of students from the Fotonas and Fizikos Olimpas schools, as well as the reflections of young, accomplished scientists working in the fields of physics and chemical engineering on their relationship with science and what inspires them in this journey.

On February 6, at the Lithuanian Academy of Sciences, the Lithuanian Science Awards Commission announced the 2024 laureates. Half of the awards were granted to Vilnius University (VU) researchers.

Rapolas Jamontas has defended his thesis entitled "Demodification by TudS Proteins: From Individual Thionucleobases to Intact tRNA" for the degree of Doctor of Science in Biochemistry.

The establishment of the Baltic Biotechnology Hub is an ambitious initiative by life sciences and biotech organizations from Lithuania, Latvia, and Estonia, aimed at uniting the region’s biotechnology sector and positioning the Baltic States as leaders in innovation. The Baltic Biotechnology Hub is not merely an infrastructure project but a new perspective that integrates the region into a unified innovation space. It is a place where solutions to the world’s most significant challenges are born, and a sustainable model for the future of the Baltic States is created. This initiative marks an exciting beginning, shaping the region's biotechnology sector for decades to come.

Raminta Baušytė has defended her thesis entitled "Characterization of human endometrial mesenchymal stem/stromal cells and their therapeutic application in vivo models of fertility disorders" for the degree of Doctor of Science in Biochemistry.

The Vilnius University Life Sciences Center has released another cohort of graduates from the Molecular Biology study program. The solemn diploma award ceremony, held in the historic Small Aula of Vilnius University, was a significant moment for the graduates, their families, and the academic community.

Irmantas Mogila has defended his thesis entitled "Mechanistic studies of type III CRISPR-Cas activity regulation and characterization of associated translation-inhibiting effectors" for the Doctor of Science in Biochemistry degree.

In the field of life sciences, where innovation is not only a key to success but also a necessity, new challenges frequently arise. Companies often lack not only technical or scientific solutions but also the interdisciplinary collaboration that is essential for developing biotechnology, medical devices, and other complex projects. Biohackathons, such as “Biospark – Hack the Future of Biotech,” are among the initiatives addressing these challenges. This event, held on December 2–4 at the newly opened Vilnius University Medical Sciences Center, united life sciences students, researchers, and business representatives. It was organized by The COINS 2025 and BSV Ventures, with support from the National Cancer Institute (NCI), which presented one of the event’s challenges.